Journals › Sri Lankan Journal of Infectious Diseases
Occult hepatitis B infection among chronic liver disease patients in Tamil Nadu: Is screening mandatory?
Sri Lankan Journal of Infectious Diseases 16(1) · 2026
https://doi.org/10.4038/sljid.v16i1.8874
Abstract
Background: Occult hepatitis B infection (OBI) is characterised by the presence of hepatitis B virus deoxyribonucleic acid (HBV DNA) in the liver, but negative for Hepatitis B surface antigen (HBsAg), irrespective of the presence of HBV DNA in blood. Chronic liver disease (CLD) is a significant contributor to mortality. Globally, OBI prevalence varies from 1% to 87%. This study aims to determine OBI prevalence among chronic liver disease patients in Tamil Nadu by screening for anti-HB total core antibodies (anti-HBc) and HBV DNA among HBsAg-negative patients.Methods: One hundred and sixty serum samples were obtained from CLD patients and tested using an enzyme-linked immunosorbent assay (ELISA) for HBsAg. The negative samples were tested for anti-HBc antibodies. The anti-HBc positive samples were tested for HBV DNA using real-time polymerase chain reaction (PCR).Results: Among the 160 samples tested by HBsAg ELISA, 98 were negative for surface antigen. These samples underwent anti-HBc testing, of which eight samples were positive. HBV DNA tested positive in five of the eight anti-HBc positive samples. The prevalence of OBI in the present study was 3.13%.Conclusion: In this study, 5% of CLD patients were diagnosed as OBI by anti-HBc assay and 3.13% by HBV DNA PCR, suggesting evidence of past exposure to HBV. To conclude, it is mandatory to diagnose OBI to prevent early progression to cirrhosis or hepatocellular carcinoma.
This index records bibliographic metadata and links to the publisher's own page. It does not host or link directly to full text.